These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9311026)

  • 41. Results of a multi-componential psychosocial intervention programme for women with early-stage breast cancer in Spain: quality of life and mental adjustment.
    Manos D; Sebastián J; Mateos N; Bueno MJ
    Eur J Cancer Care (Engl); 2009 May; 18(3):295-305. PubMed ID: 19076207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of four common stressors across the breast cancer trajectory.
    Lebel S; Rosberger Z; Edgar L; Devins GM
    J Psychosom Res; 2007 Sep; 63(3):225-32. PubMed ID: 17719358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between psychosocial factors and breast cancer: some unexpected results.
    Edwards JR; Cooper CL; Pearl SG; de Paredes ES; O'Leary T; Wilhelm MC
    Behav Med; 1990; 16(1):5-14. PubMed ID: 2322657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiological evidence for a relationship between life events, coping style, and personality factors in the development of breast cancer.
    Butow PN; Hiller JE; Price MA; Thackway SV; Kricker A; Tennant CC
    J Psychosom Res; 2000 Sep; 49(3):169-81. PubMed ID: 11110988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease.
    Galimberti V; Manika A; Maisonneuve P; Corso G; Salazar Moltrasio L; Intra M; Gentilini O; Veronesi P; Pagani G; Rossi E; Bottiglieri L; Viale G; Rotmensz N; De Cicco C; Grana CM; Sangalli C; Luini A
    Eur J Surg Oncol; 2014 Oct; 40(10):1203-8. PubMed ID: 25186914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of psychoeducation and telephone counseling on the adjustment of women with early-stage breast cancer.
    Sherman DW; Haber J; Hoskins CN; Budin WC; Maislin G; Shukla S; Cartwright-Alcarese F; McSherry CB; Feurbach R; Kowalski MO; Rosedale M; Roth A
    Appl Nurs Res; 2012 Feb; 25(1):3-16. PubMed ID: 20974079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does lymphovascular invasion predict regional nodal failure in breast cancer patients with zero to three positive lymph nodes treated with conserving surgery and radiotherapy? Implications for regional radiation.
    Boutrus R; Abi-Raad R; Niemierko A; Brachtel EF; Rizk L; Kelada A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):793-8. PubMed ID: 20171799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Alagol H
    World J Surg; 2004 Mar; 28(3):236-41. PubMed ID: 14961194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age at diagnosis in relation to survival following breast cancer: a cohort study.
    Brandt J; Garne JP; Tengrup I; Manjer J
    World J Surg Oncol; 2015 Feb; 13():33. PubMed ID: 25889186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Baseline psychosocial predictors of survival in localized melanoma.
    Lehto US; Ojanen M; Dyba T; Aromaa A; Kellokumpu-Lehtinen P
    J Psychosom Res; 2007 Jul; 63(1):9-15. PubMed ID: 17586333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of loco-regional recurrence and cancer-related death after breast cancer surgery.
    Rausei S; Rovera F; Dionigi G; Tornese D; Fachinetti A; Boni L; Dionigi R
    Breast J; 2010; 16 Suppl 1():S29-33. PubMed ID: 21050306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
    Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
    Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experiences with a specific screening instrument to identify psychosocial support needs in breast cancer patients.
    Siedentopf F; Marten-Mittag B; Utz-Billing I; Schoenegg W; Kentenich H; Dinkel A
    Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):166-71. PubMed ID: 19944516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom.
    Schoemaker MJ; Jones ME; Wright LB; Griffin J; McFadden E; Ashworth A; Swerdlow AJ
    Breast Cancer Res; 2016 Jul; 18(1):72. PubMed ID: 27418063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.
    Martín M; Ruiz A; Ruiz Borrego M; Barnadas A; González S; Calvo L; Margelí Vila M; Antón A; Rodríguez-Lescure A; Seguí-Palmer MA; Muñoz-Mateu M; Dorca Ribugent J; López-Vega JM; Jara C; Espinosa E; Mendiola Fernández C; Andrés R; Ribelles N; Plazaola A; Sánchez-Rovira P; Salvador Bofill J; Crespo C; Carabantes FJ; Servitja S; Chacón JI; Rodríguez CA; Hernando B; Álvarez I; Carrasco E; Lluch A
    J Clin Oncol; 2013 Jul; 31(20):2593-9. PubMed ID: 23733779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse life events and breast cancer: case-control study.
    Chen CC; David AS; Nunnerley H; Michell M; Dawson JL; Berry H; Dobbs J; Fahy T
    BMJ; 1995 Dec; 311(7019):1527-30. PubMed ID: 8520393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.